Avenue Therapeutics, Inc.
Q4 2024 13F Holders
Symbol
ATXI
CUSIP
05360L403
Type
Equity
Class
COM NEW
Num filings
8
Total reported value, excl. options
$385 k
Compare 2024 Q4 to
2024 Q3
2024 Q2
Manager
Report Date
Value ($000)
Shares
Option Type